Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.310
+0.020 (1.55%)
Aug 26, 2026, 1:27 PM EDT - Market open

Inovio Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.070.220.8310.261.77
Revenue Growth
--69.99%-73.83%-91.89%478.24%-76.05%
Gross Profit
-48.49-54.14-75.4-83.86-177.39-247.47
Operating Income
-79.26-86.82-112.4-126.74-253.57-301.22
Net Income
-67.43-84.95-107.25-135.12-279.82-303.66
Earnings Per Share
-1.03-1.81-3.95-6.09-14.07-17.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
36.6758.5194.11145.29253401.31
Total Debt
89.3711.8730.2132.0733.02
Net Cash (Debt)
28.6749.1482.25115.08220.92368.29
Net Cash Growth
-22.28%-40.25%-28.53%-47.91%-40.01%-1.16%
Net Cash Per Share
0.441.053.035.1911.1121.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-80.58-88.63-104.08-124.37-216.22-215.71
Capital Expenditures
-0.2-0.29-0.49-0.32-0.97-1.23
Free Cash Flow
-80.78-88.92-104.56-124.69-217.18-216.94
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
--132871.32%-51616.91%-15233.26%-2470.93%-16972.34%
Pretax Margin
--130000.00%-49254.27%-16239.87%-2726.67%-17109.87%
Profit Margin
--130000.00%-49254.27%-16239.87%-2726.67%-17109.87%
FCF Margin
--136074.45%-48019.06%-14986.17%-2116.34%-12223.61%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1829.48303.38167.3337.93591.53